21:54:34 EST Wed 18 Nov 2026
Enter Symbol
or Name
USA
CA



Telyrx Holdings Inc
Symbol TELY
Shares Issued 26,819,715
Close 2026-11-18 C$ 1.42
Market Cap C$ 38,083,995
Recent Sedar+ Documents

Telyrx Holdings CRO Lloyd resigns

2026-11-18 20:12 ET - News Release

Mr. Ben Atkins reports

TELYRX ANNOUNCES DEPARTURE OF CHIEF REVENUE OFFICER

Peter Lloyd, chief revenue officer, is leaving Telyrx Holdings Inc. to pursue other opportunities. The chief revenue officer's responsibilities will be shared among the existing leadership team in the interim.

"On behalf of the board and the company, I'd like to thank Peter for his contributions to Telyrx. We wish him every success in the future," said Ben Atkins, interim chief executive officer of Telyrx. "We have built an innovative business that fills a unique position in the large and growing market of cash-pay pharmacy. The changes we are making are to ensure the right team is in place to lead us through our next phase of growth as we continue to scale the business."

About Telyrx Holdings Inc.

Telyrx is an integrated digital healthcare platform that makes everyday prescription medications easier to access. Patients connect with independent, state-licensed health care providers who evaluate their needs and prescribe treatment when appropriate. Prescriptions are filled by Telyrx's licensed pharmacies and delivered directly to patients' doors. Serving patients across 49 U.S. states and all territories, Telyrx provides access to more than 500 common, U.S. Food and Drug Administration-approved medications for over 60 common health conditions through a seamless, convenient experience.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.